R-FARM INTERNESHNL, OOO

d. 19 k. 1 etazh 1 pom. V kom. 9, ul. Berzarina, Moscow, Russia

Also known as:

r-pharm international llc

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (7)

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis

Phase 1

Active, not recruiting

Mar 20171,880 participants

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis

Phase 1

Active, not recruiting

Jan 20171,880 participants

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis

Phase 1

Active, not recruiting

Jan 20171,880 participants

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis

Phase 1

Active, not recruiting

Jan 20171,880 participants

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy

Phase 1

Active, not recruiting

Jun 20161,575 participants

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-a) Inhibitor Therapy

Phase 1

Active, not recruiting

Apr 2016368 participants

Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy

Phase 1

Active, not recruiting

Mar 20161,575 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations